Impact of Genetic Polymorphisms and Drug-Drug Interactions on Clopidogrel and Prasugrel Response Variability

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|11|8|667-677

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.11, Iss.8, 2010-10, pp. : 667-677

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment

By Gschwind Liliane   Rollason Victoria   Boehlen Françoise   Rebsamen Michela   Combescure Christophe   Grünenwald Michèle   Matthey Alain   Bonnabry Pascal   Dayer Pierre   Desmeules Jules Alexandre  

Pharmacogenomics, Vol. 14, Iss. 7, 2013-05 ,pp. : 745-753

Future Medicine

Access to resources Recommend Favorite

Cytochrome P450 Part 3: Impact of Drug‐Drug Interactions

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 39, Iss. 1, 2009-03 ,pp. : 55-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug-Gene Interactions between Genetic Polymorphisms and Antihypertensive Therapy

By Hedi Schelleman   Bruno H. Ch. Stricker  

Drugs, Vol. 64, Iss. 16, 2004-01 ,pp. : 1801-1816

Adis International

Access to resources Recommend Favorite

Maraviroc potential drug-drug interactions

By  

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Transporter-mediated drug––drug interactions

By Müüller Fabian   Fromm Martin F  

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 1017-1037

Future Medicine

Access to resources Recommend Favorite